Filing Details
- Accession Number:
- 0001140361-18-030008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-26 20:23:49
- Reporting Period:
- 2018-06-22
- Accepted Time:
- 2018-06-26 20:23:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1274826 | Robert Baffi | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-22 | 6,949 | $14.39 | 90,225 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-06-22 | 6,621 | $99.00 | 83,604 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-06-22 | 328 | $99.01 | 83,276 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2018-06-22 | 6,949 | $0.00 | 6,949 | $14.39 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-11-12 | 2019-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 77,055 | Indirect | Shares held by Baffi Family Trust |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.